Logo

Overbrook to Distribute Phytronix Ionization Technology

May 01, 2009

NEW YORK (GenomeWeb News) – Overbrook Scientific will distribute Phytronix's laser diode thermal desorption ionization technology to labs in the US, under an agreement announced today.

According to Boston-based Overbrook, the LDTD technology can increase the speed of analyzing compounds 20 to 100 times compared to established techniques based on liquid chromatography with mass spectrometry. The technology can be added to any LC-MS/MS system, said Overbrook, which also claims that the technology offers a better price and performance over APCI and MALDI techniques.

Further terms of the collaboration were not disclosed.

Filed under

Proteomics & Protein Research
proteomics
Breaking News
The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.